Assessment of antioxidants biomarkers in plasma of Fragile X syndrome patients
El-Mahdy, R., Amer, N., Meguid, N., Hashish, A., Salem, S., Ali, O. (2022). Assessment of antioxidants biomarkers in plasma of Fragile X syndrome patients. EKB Journal Management System, 2(2), 43-51. doi: 10.21608/aijpms.2022.93451.1088
Rasha S El-Mahdy; Noha N Amer; Nagwa A Meguid; Adel Hashish; Sohair Salem; Ola Ali. "Assessment of antioxidants biomarkers in plasma of Fragile X syndrome patients". EKB Journal Management System, 2, 2, 2022, 43-51. doi: 10.21608/aijpms.2022.93451.1088
El-Mahdy, R., Amer, N., Meguid, N., Hashish, A., Salem, S., Ali, O. (2022). 'Assessment of antioxidants biomarkers in plasma of Fragile X syndrome patients', EKB Journal Management System, 2(2), pp. 43-51. doi: 10.21608/aijpms.2022.93451.1088
El-Mahdy, R., Amer, N., Meguid, N., Hashish, A., Salem, S., Ali, O. Assessment of antioxidants biomarkers in plasma of Fragile X syndrome patients. EKB Journal Management System, 2022; 2(2): 43-51. doi: 10.21608/aijpms.2022.93451.1088

Assessment of antioxidants biomarkers in plasma of Fragile X syndrome patients

Azhar International Journal of Pharmaceutical and Medical Sciences
Article 5, Volume 2, Issue 2, June 2022, Page 43-51  XML PDF (427.64 K)
Document Type: Original research articles
DOI: 10.21608/aijpms.2022.93451.1088
View on SCiNiTO View on SCiNiTO
Authors
Rasha S El-Mahdy email 1; Noha N Amer2; Nagwa A Meguid1; Adel Hashish1; Sohair Salem3; Ola Aliorcid 2
1Department of Research on Children with Special Needs, National Research Centre, Giza, Egypt
2Department of Biochemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt
3Department of Molecular Genetics and Enzymology, National Research Centre, Giza, Egypt
Abstract
Numerous neurological diseases are exacerbated by oxidative stress, including fragile x syndrome (FXS), which occurred as a result of a mutation in the fragile x mental retardation 1 gene (FMR 1-gene). Several studies have found that redox equilibrium is disrupted in the brains of knockout mice with fragile x syndrome, suggesting that antioxidant levels in plasma may reflect the oxidative stress profile in FXS. The goal of this study aimed to evaluate antioxidants biomarker levels in FXS patients indicating that antioxidants can be used as indicators in FXS patients. This study included a total of 60 subjects (30 suspected FXS patients: 15 males and 15 females, while the remaining 30 were healthy subjects). Full blood genomic DNA was used, followed by gel electrophoresis and CGG repeat calculation. Antioxidant biomarkers (total glutathione, glutathione peroxidase, and superoxide dismutase) were measured in the plasma of patients and controls groups. The study revealed that the average levels of antioxidant biomarkers in FXS patients were significantly lower than in controls. FXS and oxidative stress are linked, implying that oxidative stress plays a role in the pathogenic process. Antioxidants may be helpful in the therapy of FXS.
Keywords
Fragile X syndrome; oxidative stress; antioxidants; total glutathione; glutathione peroxidase; superoxide dismutase
Statistics
Article View: 252
PDF Download: 139